PNAS 2013-12-17

Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.

Joshua Bakhsheshian, Bih-Rong Wei, Ki-Eun Chang, Suneet Shukla, Suresh V Ambudkar, R Mark Simpson, Michael M Gottesman, Matthew D Hall

Index: Proc. Natl. Acad. Sci. U. S. A. 110(51) , 20801-6, (2013)

Full Text: HTML

Abstract

ATP-binding cassette (ABC) transporters are a group of transmembrane proteins that maintain chemical homeostasis through efflux of compounds out of organelles and cells. Among other functions, ABC transporters play a key role in protecting the brain parenchyma by efflux of xenobiotics from capillary endothelial cells at the blood-brain barrier (BBB). They also prevent the entry of therapeutic drugs at the BBB, thereby limiting their efficacy. One of the key transporters playing this role is ABCG2. Although other ABC transporters can be studied through various imaging modalities, no specific probe exists for imaging ABCG2 function in vivo. Here we show that D-luciferin, the endogenous substrate of firefly luciferase, is a specific substrate for ABCG2. We hypothesized that ABCG2 function at the BBB could be evaluated by using bioluminescence imaging in transgenic mice expressing firefly luciferase in the brain. Bioluminescence signal in the brain of mice increased with coadministration of the ABCG2 inhibitors Ko143, gefitinib, and nilotinib, but not an ABCB1 inhibitor. This method for imaging ABCG2 function at the BBB will facilitate understanding of the function and pharmacokinetic inhibition of this transporter.